ICT Mumbai, ITRI sign EOI to catalyse ₹30 cr for construction of Mumbai Biocluster building

Read more

Why India’s B.Pharm graduates need a standardised National Exit Exam

Read more

Exclusive interview with Dilip Singh Rathod, President India Business, JB Pharma

Read more

Diagnosed prevalent cases of HER2- breast cancer across 8MM set to reach 4.12 mn in 2034

Read more

Pfizer completes licensing agreement with 3SBio

Read more

India overtakes Iran in clinical trial initiations outside North America and Europe in Q2 2025

Read more

Baxdrostat met primary, secondary endpoints in BaxHTN Phase III trial in patients with treatment-resistant hypertension

Read more

Zydus gains tentative approval from USFDA for Ibrutinib tablets 140 mg, 280 mg, and 420 mg

Read more

Kilitch Drugs to raise around ₹50 crore via rights issue at Rs. 375 per share

Read more

Lupin gains US FDA approvals for Liraglutide and Glucagon Injectable Products

Read more